Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?

MLA

Amorim, Viviane Brandão, et al. “Can Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Be Used to Avoid Liver Biopsy in Patients with Nonalcoholic Fatty Liver Disease?” World Journal of Hepatology, vol. 12, no. 9, Sept. 2020, pp. 661–71. EBSCOhost, https://doi.org/10.4254/wjh.v12.i9.661.

APA

Amorim, V. B., Parente, D. B., Paiva, F. F., Oliveira Neto, J. A., Miranda, A. A., Moreira, C. C., Fernandes, F. F., Campos, C. F. F., Leite, N. C., Perez, R. de M., & Rodrigues, R. S. (2020). Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World Journal of Hepatology, 12(9), 661–671. https://doi.org/10.4254/wjh.v12.i9.661

Chicago

Amorim, Viviane Brandão, Daniella Braz Parente, Fernando Fernandes Paiva, Jaime Araújo Oliveira Neto, Amanda Almeida Miranda, Cláudia Cravo Moreira, Flávia Ferreira Fernandes, et al. 2020. “Can Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Be Used to Avoid Liver Biopsy in Patients with Nonalcoholic Fatty Liver Disease?” World Journal of Hepatology 12 (9): 661–71. doi:10.4254/wjh.v12.i9.661.